These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 34296720)
41. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy. Heinemann F; Karges J; Gasser G Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879 [TBL] [Abstract][Full Text] [Related]
42. Synthesis, characterization and biological evaluation of mixed-ligand ruthenium(II) complexes for photodynamic therapy. Huang H; Zhang P; Yu B; Jin C; Ji L; Chao H Dalton Trans; 2015 Oct; 44(39):17335-45. PubMed ID: 26387554 [TBL] [Abstract][Full Text] [Related]
43. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells. Lin M; Zou S; Liao X; Chen Y; Luo D; Ji L; Chao H Chem Commun (Camb); 2021 May; 57(36):4408-4411. PubMed ID: 33949487 [TBL] [Abstract][Full Text] [Related]
44. Photosensitive Ru(II) Complexes as Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4. Toupin N; Steinke SJ; Nadella S; Li A; Rohrabaugh TN; Samuels ER; Turro C; Sevrioukova IF; Kodanko JJ J Am Chem Soc; 2021 Jun; 143(24):9191-9205. PubMed ID: 34110801 [TBL] [Abstract][Full Text] [Related]
45. Minimal Functionalization of Ruthenium Compounds with Enhanced Photoreactivity against Hard-to-Treat Cancer Cells and Resistant Bacteria. Oliveira GFS; Gouveia FS; Andrade AL; de Vasconcelos MA; Teixeira EH; Palmeira-Mello MV; Batista AA; Lopes LGF; de Carvalho IMM; Sousa EHS Inorg Chem; 2024 Aug; 63(31):14673-14690. PubMed ID: 39042379 [TBL] [Abstract][Full Text] [Related]
46. A novel ruthenium polypyridyl complex for the selective imaging and photodynamic targeting of the Golgi apparatus. Zhao F; Wang W; Wu W Dalton Trans; 2021 Mar; 50(10):3536-3541. PubMed ID: 33599670 [TBL] [Abstract][Full Text] [Related]
47. Two novel BODIPY-Ru(ii) arene dyads enabling effective photo-inactivation against cancer cells. Wang T; Hou Y; Chen Y; Li K; Cheng X; Zhou Q; Wang X Dalton Trans; 2015 Jul; 44(28):12726-34. PubMed ID: 26087131 [TBL] [Abstract][Full Text] [Related]
48. A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent. Chen J; Tao Q; Wu J; Wang M; Su Z; Qian Y; Yu T; Wang Y; Xue X; Liu HK J Inorg Biochem; 2020 Sep; 210():111132. PubMed ID: 32569884 [TBL] [Abstract][Full Text] [Related]
49. Photoactivated full-API nanodrug (FAND): harnessing transition metal complexes and MTH1 inhibitor for enhanced DNA damage in cancer cells. Zhu H; Cui M; Tang Q; Zhao H; Zhang P; Zeng S; Li W; Zhou Q; Zhang J; Chen Y Biomater Sci; 2024 Jun; 12(12):3154-3162. PubMed ID: 38687170 [TBL] [Abstract][Full Text] [Related]
50. Near-IR/Visible-Emitting Thiophenyl-Based Ru(II) Complexes: Efficient Photodynamic Therapy, Cellular Uptake, and DNA Binding. Zhang SQ; Meng TT; Li J; Hong F; Liu J; Wang Y; Gao LH; Zhao H; Wang KZ Inorg Chem; 2019 Oct; 58(20):14244-14259. PubMed ID: 31595752 [TBL] [Abstract][Full Text] [Related]
51. Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro. Aksakal NE; Tanrıverdi Eçik E; Kazan HH; Yenilmez Çiftçi G; Yuksel F Photochem Photobiol Sci; 2019 Aug; 18(8):2012-2022. PubMed ID: 31282525 [TBL] [Abstract][Full Text] [Related]
52. Development of Ruthenium Nanophotocages with Red or Near-Infrared Light-Responsiveness. Zhang Z; He M; Wang R; Fan J; Peng X; Sun W Chembiochem; 2023 Dec; 24(24):e202300606. PubMed ID: 37837285 [TBL] [Abstract][Full Text] [Related]
53. Strong Influence of Ancillary Ligands Containing Benzothiazole or Benzimidazole Rings on Cytotoxicity and Photoactivation of Ru(II) Arene Complexes. Lari M; Martínez-Alonso M; Busto N; Manzano BR; Rodríguez AM; Acuña MI; Domínguez F; Albasanz JL; Leal JM; Espino G; García B Inorg Chem; 2018 Nov; 57(22):14322-14336. PubMed ID: 30379535 [TBL] [Abstract][Full Text] [Related]
54. Visible and Red Light-Triggered Anticancer Profile of a Ferrocene-Re(I)-Tricarbonyl Conjugate: Experimental and Theoretical Studies. Kushwaha R; Upadhyay A; Peters S; Yadav AK; Mishra A; Bera A; Sadhukhan T; Banerjee S Langmuir; 2024 Jun; 40(23):12226-12238. PubMed ID: 38814099 [TBL] [Abstract][Full Text] [Related]
55. Fusion of photodynamic therapy and photoactivated chemotherapy: a novel Ru(II) arene complex with dual activities of photobinding and photocleavage toward DNA. Chen Y; Lei W; Jiang G; Hou Y; Li C; Zhang B; Zhou Q; Wang X Dalton Trans; 2014 Nov; 43(41):15375-84. PubMed ID: 25188424 [TBL] [Abstract][Full Text] [Related]
56. Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents. Liu J; Chen Y; Li G; Zhang P; Jin C; Zeng L; Ji L; Chao H Biomaterials; 2015 Jul; 56():140-53. PubMed ID: 25934287 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers. Hess J; Huang H; Kaiser A; Pierroz V; Blacque O; Chao H; Gasser G Chemistry; 2017 Jul; 23(41):9888-9896. PubMed ID: 28509422 [TBL] [Abstract][Full Text] [Related]
58. Substituent effect and wavelength dependence of the photoinduced Ru-O homolysis in the [Ru(bpy)2(py-SO3)](+)-type complexes. Zheng Y; Zhou QX; Zhang YY; Li C; Hou YJ; Wang XS Dalton Trans; 2016 Feb; 45(7):2897-905. PubMed ID: 26752625 [TBL] [Abstract][Full Text] [Related]
59. Light-activated ruthenium complexes photobind DNA and are cytotoxic in the photodynamic therapy window. Wachter E; Heidary DK; Howerton BS; Parkin S; Glazer EC Chem Commun (Camb); 2012 Oct; 48(77):9649-51. PubMed ID: 22908094 [TBL] [Abstract][Full Text] [Related]
60. Polymeric Encapsulation of a Ruthenium Polypyridine Complex for Tumor Targeted One- and Two-Photon Photodynamic Therapy. Karges J; Li J; Zeng L; Chao H; Gasser G ACS Appl Mater Interfaces; 2020 Dec; 12(49):54433-54444. PubMed ID: 33238711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]